In vitro vascularization of a combined system based on a 3D printing technique

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 10, 2016, Pages 833-842

  Zhao, Xinru ^a   Liu, Libiao ^a   Wang, Jiayin ^a   Xu, Yufan ^a   Zhang, Weiming ^a   Khang, Gilson ^b   Wang, Xiaohong ^a,c  

^a TSINGHUA UNIVERSITY   (China)

^b Chonbuk National University   (South Korea)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

adipose derived stem cells (ADSCs); combined construct; endothelial cells; fibrin collagen hydrogel; poly(dl lactic co glycolic acid) (PLGA); three dimensional (3D) printing

Indexed keywords

3D PRINTERS; BIOMECHANICS; COPYRIGHTS; CYTOLOGY; ENDOTHELIAL CELLS; MUSCLE; SCAFFOLDS (BIOLOGY); STEM CELLS; TEMPERATURE;

ADIPOSE DERIVED STEM CELLS; ADIPOSE-DERIVED STEM CELL; COMBINED CONSTRUCT; ENDOTHELIAL-CELLS; FIBRIN/COLLAGEN HYDROGEL; IN-VITRO; POLY(DL-LACTIC-CO-GLYCOLIC ACID); POLY-DL-LACTIC-CO-GLYCOLIC ACIDS; THREE-DIMENSIONAL (3D) PRINTING; VASCULARIZATION;

HYDROGELS;

COLLAGEN; FIBRIN; POLYGLACTIN; SCATTER FACTOR; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; BIOMECHANICS; CELL DIFFERENTIATION; CELL ENCAPSULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HYDROGEL; IN VITRO STUDY; LOW TEMPERATURE PROCEDURES; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CELL; THREE DIMENSIONAL PRINTING; TISSUE SCAFFOLD; VASCULARIZATION;

EID: 85028271843     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1863     Document Type: Article

References (53)

1. Ahmed TAE, Dare EV, Hincke M. 2008; Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 14: 199–215.
2. Breen A, O'Brien T, Pandit A. 2009; Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev 15: 201–214.
3. Cao Y, Meng Y, Sun Z, et al. 2005; Potential of human adipose tissue derived adult stem cells differentiate into endothelial cells. Acta Acad Med Sin 27: 678–682.
4. 1 reveals the engagement of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am J Pathol 162: 533–546.
5. Cui TK, Wang XH, Yan YN, et al. 2009; Rapid prototyping a new polyurethane-collagen conduit and its Schwann cell compatibility. J Bioact Compat Polym 24: 5–7.
6. Griffith CK, Miller C, Sainson RCA, et al. 2005; Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 11: 257–266.
7. He K, Wang XH. 2011; Rapid prototyping of tubular polyurethane and cell/hydrogel construct. J Bioact Compat Polym 26: 363–374.
8. Hellstrom M, Gerhardt H, Kalen M, et al. 2001; Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543–553.
9. Hoffman AS. 2002; Hydrogels for biomedical applications. Adv Drug Deliv Rev 43: 3–12.
10. Jain RK. 2003; Molecular regulation of vessel maturation. Nature Med 9: 685–693.
11. Jang I-K, Hursting MJ. 2005; When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 111: 2671–2683.
12. Kaully T, Kaufman K, Lesman A, et al. 2009; Vascularization – the conduit to viable engineered tissues. Tissue Eng Part B Rev 15: 159–169.
13. Koike N, Fukunura D, Gralla O, et al. 2004; Tissue engineering: creation of long-lasting blood vessels. Nature 428: 138–139.
14. Li RK, Yau TM, Weisel RD, et al. 2000; Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg 119: 368–375.
15. Li SJ, Xiong Z, Wang XH, et al. 2009a; Direct fabrication of a hybrid cell/hydrogel construct via a double-nozzle assembling technology. J Bioact Compat Polym 24: 249–264.
16. Li SJ, Yan YN, Xiong Z, et al. 2009b; Gradient hydrogel construct based on an improved cell assembling system. J Bioact Compat Polym 24: 84–99.
17. Martin I, Vunjak-Novakovic G, Yang J, et al. 1999; Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res 253: 681–688.
18. Oberpenning F, Meng J, Yoo JJ, et al. 1999; De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 17: 149–155.
19. Obradovic B, Carrier RL, Vunjak-Novakovic G, et al. 1999; Gas exchange is essential for bioreactor cultivation of tissue engineered cartilage. Biotechnol Bioeng 63: 197–205.
20. Pepper MS. 1997; Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21–43.
21. Poulsom R, Alison MR, Forbes SJ, et al. 2002; Adult stem cell plasticity. J Pathol 197: 441–456.
22. Sakiyama SE, Schense JC, Hubbell JA. 1999; Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J 13: 2214–2224.
23. Simper D, Stalboerger PG, Panetta CJ, et al. 2002; Smooth muscle progenitor cells in human blood. Circulation 106: 1199–1204.
24. Situ ZQ, Wu J (eds). 2007; Cell Culture, 2nd edn. Xi'an World Publishing Corporation: Xi'an; 119, 196, 200.
25. Stegemann JP, Kaszuba SN, Rowe SL. 2007; Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng 13: 2601–2613.
26. Wang XH. 2012; Intelligent freeform manufacturing of complex organs. Artif Organs 36: 951–961.
27. Wang XH. 2013; Overview on biocompatibilities of implantable biomaterials. In Advances in Biomaterials Science and Applications in Biomedicine, R Lazinica (ed). InTech: Rijeka, Croatia 111–155.
28. Wang XH, Sui SC. 2011; Pulsatile culture of a poly(dl-lactic-co-glycolic acid) sandwiched cell/hydrogel construct fabricated using a step-by-step mold/extraction methods. Artif Organs 35: 645–655.
29. Wang XH, Zhang QQ. 2011; Overview on ‘Chinese-Finnish Workshop on Biomanufacturing and Evaluation Techniques’. Artif Organs 35: E191–E193.
30. Wang XH, Ma JB, Wang YN, et al. 2001; Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements. Biomaterials 22: 2247–2255.
31. Wang XH, Ma JB, Feng QL, et al. 2002a; Skeletal repair in rabbits with calcium phosphate cements incorporated phosphorylated chitin. Biomaterials 23: 4591–4600.
32. Wang XH, Ma JB, Wang YN, et al. 2002b; Skeletal repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements. Biomaterials 23: 4167–4176.
33. Wang XH, Cui FZ, Feng QL, et al. 2003a; Preparation and characterization of collagen/chitosan matrices as potential biomaterials. J Bioact Compat Polym 18: 453–467.
34. Wang XH, Li DP, Wang WJ, et al. 2003b; Crosslinked collagen/chitosan matrix for artificial livers. Biomaterials 24: 3213–3220.
35. Wang XH, Ma JB, Feng QL, et al. 2003c; In vivo evaluation of S-chitosan enhanced calcium phosphate cements. J Bioact Compat Polym 18: 259–271.
36. Wang XH, Yan YN, Lin F, et al. 2005; Preparation and characterization of a collagen/chitosan/heparin matrix for an implantable bioartificial liver. J Biomater Sci Polym Ed 16: 1063–1080.
37. Wang XH, Yan YN, Pan YQ, et al. 2006; Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng 12: 83–90.
38. Wang XH, Yan YN, Zhang RJ. 2007; Rapid prototyping as a tool for manufacturing bioartificial livers. Trends Biotechnol 25: 505–513.
39. Wang XH, Yu X, Yan YN, et al. 2008; Liver tissue responses to gelatin and gelatin/chitosan gels. J Biomed Mater Res 87A: 62–68.
40. Wang XH, Cui TK, Yan YN, et al. 2009; Peroneal nerve regeneration along a new polyurethane-collagen conduit and its Schwann cell compatibility. J Bioact Compat Polym 24: 109–127.
41. Wang XH, Sui SC, Yan YN, et al. 2010a; Design and fabrication of PLGA sandwiched cell/hydrogel constructs for complex organ regeneration. J Bioact Compat Polym 25: 229–240.
42. Wang XH, Yan YN, Zhang RJ. 2010b; Recent trends and challenges in complex organ manufacturing. Tissue Eng Part B Rev 16: 189–197.
43. Wang XH, Yan YN, Zhang RJ. 2010c; Gelatin-based hydrogels for controlled cell assembly. In Biomedical Applications of Hydrogels Handbook Ottenbrite RM (ed). Springer: New York, NY; 269–284.
44. Wang XH, Mäkitie AA, Poloheimo K-S, et al. 2011; Characterization of a PLGA sandwiched cell/fibrin tubular construct and induction of the adipose derived stem cells into smooth muscle cells. Mater Sci Eng C Mater Biol Appl 31: 801–808.
45. Wang XH, Tuomi J, Mäkitie AA, et al. 2013; The integrations of biomaterials and rapid prototyping techniques for intelligent manufacturing of complex organs. In: Advances in Biomaterials Science and Applications in Biomedicine, R Lazinica (ed). InTech: Rijeka, Croatia 437–463.
46. Weisel JW. 2005; Fibrinogen and fibrin. Adv Protein Chem 70: 247–299.
47. Xu W, Wang XH, Yan YN, et al. 2007; Rapid prototyping three-dimensional cell/gelatin/fibrinogen constructs for medical regeneration. J Bioact Compat Polym 22: 363–377.
48. Xu W, Wang XH, Yan YN, et al. 2008; Rapid prototyping of polyurethane for the creation of vascular systems. J Bioact Compat Polym 23: 103–114.
49. Yan YN, Wang XH, Pan YQ, et al. 2005a; Fabrication of viable tissue-engineered constructs with 3D cell-assembly technique. Biomaterials 26: 5864–5871.
50. Yan YN, Wang XH, Xiong Z, et al. 2005b; Direct construction of a three-dimensional structure with cells and hydrogel. J Bioact Compat Polym 20: 259–269.
51. Zhang T, Yan YN, Wang XH, et al. 2007; Three-dimensional gelatin and gelatin/hyaluronan hydrogel structures for traumatic brain injury. J Bioact Compat Polym 22: 19–29.
52. Zhao XR, Wang XH. 2013; Preparation of an adipose-derived stem cell/fibrin-poly (d,l-lactic-co-glycolic acid) construct based on a rapid prototyping technique. J Bioact Compat Polym 28: 191–203.
53. Zisch AH, Schenk U, Schense JC, et al. 2001; Covalently conjugated VEGF–fibrin matrices for endothelialization. J Control Release 72: 101–113.